Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Romanelli, F.
Right arrow Articles by Berger, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Romanelli, F.
Right arrow Articles by Berger, J.
Neurology 2000;54:1404-1407
© 2000 American Academy of Neurology


Views & Reviews

Therapeutic dilemma

The use of anticonvulsants in HIV-positive individuals

F. Romanelli, PharmD, H. R. Jennings, PharmD, A. Nath, MD, M. Ryan, PharmD and J. Berger, MD

From the University of Kentucky Medical Center and College of Pharmacy (Drs. Romanelli, Jennings, and Ryan), Division of Neurology (Drs. Nath and Berger) Lexington, KY.

Address correspondence and reprint requests to Dr. Frank Romanelli, University of Kentucky Medical Center, 800 Rose Street, C-117 Lexington, KY 40536.

The concurrent use of anticonvulsants and antiretrovirals is a poorly studied area that poses a therapeutic dilemma for the clinician caring for HIV-positive patients requiring both classes of medications. Anticonvulsants and antiretrovirals may interact through multiple mechanisms including competition for protein binding, enhanced or reduced liver metabolism, and increased viral replication. The authors present many of the challenges faced by clinicians caring for HIV-positive patients who may require anticonvulsant therapy.

Key words: Anticonvulsant—Seizure—HIV




This article has been cited by other articles:


Home page
Am J Health Syst PharmHome page
M. Dickson, T. J. Bramley, C. Kozma, D. Doshi, and M. F. T. Rupnow
Potential drug-drug interactions with antiepileptic drugs in Medicaid recipients
Am. J. Health Syst. Pharm., September 15, 2008; 65(18): 1720 - 1726.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
D. E Bates and R. J Herman
Carbamazepine Toxicity Induced by Lopinavir/Ritonavir and Nelfinavir
Ann. Pharmacother., June 1, 2006; 40(6): 1190 - 1195.
[Abstract] [Full Text] [PDF]


Home page
Journal of Pharmacy PracticeHome page
S. A. Krikorian and D. C. Rudorf
Drug-Drug Interactions and HIV Therapy: What Should Pharmacists Know?
Journal of Pharmacy Practice, August 1, 2005; 18(4): 278 - 294.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.